Literature DB >> 9041358

Leishmania aethiopica derived from diffuse leishmaniasis patients preferentially induce mRNA for interleukin-10 while those from localized leishmaniasis patients induce interferon-gamma.

H Akuffo1, K Maasho, M Blostedt, B Höjeberg, S Britton, M Bakhiet.   

Abstract

Exposure of peripheral blood mononuclear cells to promastigotes of Leishmania aethiopica derived from patients with the self-limiting, localized form of the disease (local cutaneous leishmaniasis; LCL) preferentially induced mRNA for interferon (IFN)-gamma but little for interleukin (IL)-10. In contrast, stimulation of the same cells with promastigotes derived from patients with the persistent, disseminated form of the disease (diffuse cutaneous leishmaniasis; DCL) stimulated the expression of IL-10 rather than IFN-gamma. In general, parasites derived from LCL patients induced more expression of other cytokines tested, including IL-4, IL-6, and transforming growth factor-beta, although tumor necrosis factor-alpha was equivalent in cultures stimulated with LCL or DCL promastigotes. The results suggest that the antigen-specific immunosuppression observed in DCL patients and the resulting clinical picture could in part be due to the properties of the infecting parasite to induce more IL-10 than IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9041358     DOI: 10.1093/infdis/175.3.737

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors.

Authors:  S Nylén; U Mörtberg; D Kovalenko; I Satti; K Engström; M Bakhiet; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis.

Authors:  K Maasho; D Wolday; M Edjigu; K Söderström; S Britton; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

3.  Coiling phagocytosis of trypanosomatids and fungal cells.

Authors:  M G Rittig; K Schröppel; K H Seack; U Sander; E N N'Diaye; I Maridonneau-Parini; W Solbach; C Bogdan
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

5.  Systemic FasL and TRAIL neutralisation reduce leishmaniasis induced skin ulceration.

Authors:  Geremew Tasew; Susanne Nylén; Thorsten Lieke; Befekadu Lemu; Hailu Meless; Nicolas Ruffin; Dawit Wolday; Abraham Asseffa; Hideo Yagita; Sven Britton; Hannah Akuffo; Francesca Chiodi; Liv Eidsmo
Journal:  PLoS Negl Trop Dis       Date:  2010-10-12

6.  Human immunodeficiency virus and leishmaniasis.

Authors:  Navid Ezra; Maria Teresa Ochoa; Noah Craft
Journal:  J Glob Infect Dis       Date:  2010-09

7.  Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.

Authors:  K Maasho; D McMahon-Pratt; J Raita; M Raud; S Britton; L Soong; H Akuffo
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 8.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

9.  T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.

Authors:  Tobias Schwarz; Katharina A Remer; Wiebke Nahrendorf; Anita Masic; Lisa Siewe; Werner Müller; Axel Roers; Heidrun Moll
Journal:  PLoS Pathog       Date:  2013-06-27       Impact factor: 6.823

10.  Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia.

Authors:  Tamrat Abebe; Asrat Hailu; Mihretu Woldeyes; Woinshet Mekonen; Kassahun Bilcha; Thomas Cloke; Lionel Fry; Nafisa-Katrin Seich Al Basatena; Karina Corware; Manuel Modolell; Markus Munder; Fabienne Tacchini-Cottier; Ingrid Müller; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.